Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders — Pittsburgh, Pennsylvania

Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Mucopolysaccharidosis II, Mucopolysaccharidosis Type II (MPS II).

Sponsors: REGENXBIO Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

• University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center
• UPMC Presbyterian Shadyside Hospital
• University of Pittsburgh Physicians
• University of Pittsburgh Division of Pulmonary
• ENT Department, Children's Hospital of Pittsburgh
• Site US10167 University of Pittsburgh Medical Center
• University of Pittsburgh Medical Center, CHF/Transplantation Cardiology
• UPMC Children's Hospital
• Duplicate_Allegheny General Hospital /ID# 215585
• University of Pittsburgh MC /ID# 65486
• UPMC Hillman Cancer Center, Magee-Womens Hospital
• University of Pittsburgh Medical Center Department of Dermatology

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders?

Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders conducted?

Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has 3 clinical trials on record, with 1 currently active. Their work covers Mucopolysaccharidosis II, Mucopolysaccharidosis Type II (MPS II).

Is Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders accredited by Crixeo Clinical Trials?

Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.